Skip to content
Open access

Integrated multi-omics reveals stable microbe–metabolite relationships in pediatric celiac disease

Jul 2026 · Frontiers in Microbiology · Vol 17 · 0 citations · 100 references
Medicine

TL;DR

The results support prioritizing a concise list of reproducible candidate features for mechanistic validation and longitudinal treatment monitoring in more extensive cohorts, rather than for immediate diagnostic application.

Abstract

Celiac disease is a lifelong immune-mediated disease triggered by dietary gluten and managed exclusively through a strict gluten-free diet. Differences in the gut microbiome are consistently observed in celiac disease, yet the associated metabolic consequences remain insufficiently defined. This study evaluated the stool microbiome-metabolome relationship in children from Canterbury, New Zealand, a region with a notably high prevalence of celiac disease (∼ 1 in 82). Eleven children with untreated celiac disease and 10 controls were assessed, with nine children resampled after 6 months of gluten-free diet adherence. Stool samples were subjected to 16S rRNA sequencing, targeted and untargeted metabolomic profiling, and multi-omics integration using cross-block and machine-learning approaches. Celiac disease was characterized by consistent reproducible changes in a small set of resampled-stable taxa and metabolites, rather than a uniform shift. The most prominent finding was rearrangement within Bacteroides rather than a uniform shift: B. ovatus increased reproducibly in both untreated and treated disease, while integration analyses associated B. fragilis with celiac disease and B. vulgatus with controls. Metabolite changes were observed in two linked axes: a butyrate-led fermentation signature and a redox and organic acid signature, both elevated in untreated disease and shifting toward control levels after 6 months of gluten-free diet. Recovery was partial, and the diet imposed its own signature, notably an increase in the fat-responsive pathobiont Bilophila wadsworthia. Machine learning discrimination was modest (ROC-AUC = 0.66–0.68, PR-AUC = 0.73–0.79), but the microbiome and metabolome aligned along one reproducible cross-omic axis. The results support prioritizing a concise list of reproducible candidate features for mechanistic validation and longitudinal treatment monitoring in more extensive cohorts, rather than for immediate diagnostic application.

Read PDF

Similar papers

Open access Sep 2026

Long-Read Metagenomic Sequencing Reveals Persistent Gut Microbiome Alterations in Children with Celiac Disease in Remission

The findings suggest a distinct microbial ecosystem during histologic remission characterized by residual taxonomic dysbiosis and functional constraints, accompanied by adaptive remodeling that may promote mucosal healing.

David Le, Daniel M. Portik, Takumi Konno et al. · 0 citations
Open access Aug 2026

Integrated multi-omics profiling identifies a convergent gut-metabolic-immune signature in Alzheimer's disease.

These findings define a convergent gut-metabolic-immune axis in AD where systemic oxidative stress serves as a central hub, providing specific, measurable redox biomarkers and mechanistic insights for noninvasive screening and therapeutic targeting.

Zong-Xin Ling, Xiao-Cui Xu, Yi-Wen Cheng et al. · 1 citation
Open access Aug 2026

Integrated multi-omics analysis identifies microbial and metabolic signatures and drivers of CNS autoimmunity

Interactions between diet and commensal gut microbiota profoundly impact the levels of immunomodulatory systemic metabolites, including several that are associated with disease in people with MS (pwMS), and individual gut microbiota-produced metabolites are sufficient to worsen disease in a mouse model of MS.

T. Montgomery, Emily A. Nelson, Lauren A. Downs et al. · 0 citations
Open access Oct 2026

Functional microbiome shifts are associated with neuroinflammatory outcomes under dietary interventions in multiple sclerosis

Multiple sclerosis (MS) is a chronic immune-mediated disease of the central nervous system. While disease-modifying therapies can reduce relapse rates, their limitations have spurred interest in adjunctive approaches such as fasting and ketogenic diets (FD, KD). In a randomized controlled trial, participants with relap...

Friederike Gutmann, L. S. Bahr, Ulrike Bruning et al. · 0 citations
Open access Aug 2026

Integrated multi-omics reveals dysbiosis in hemodialysis patients: A multi-center study

Introduction The gut microbiome-metabolome interplay in hemodialysis (HD) patients remains poorly characterized. Using multi-omics approaches, we compared HD patients with healthy controls (HC) to identify microbial signatures, metabolic perturbations, and their integrated correlations. Methods This case-control study...

Xinyue Zhang, Dan Yu, Yu-Qing Cui et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.